RITUXIMAB-ABBS

4838 reported adverse events

Drug classes: CD20-directed Cytolytic Antibody [EPC]

These side effects are most commonly reported by patients taking RITUXIMAB-ABBS:

# Side effect Count
0 OFF LABEL USE 2299
1 INTENTIONAL PRODUCT USE ISSUE 323
2 HYPERTENSION 254
3 PAIN 249
4 RHEUMATOID ARTHRITIS 239
5 FATIGUE 238
6 DYSPNOEA 229
7 INTENTIONAL DOSE OMISSION 227
8 INFUSION RELATED REACTION 224
9 DRUG INEFFECTIVE 222
See all common reactions for RITUXIMAB-ABBS

RITUXIMAB-ABBS is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 CHEILECTOMY 2 0.6667
1 ADMINISTRATION SITE FIBROSIS 2 0.5000
2 AIRWAY PEAK PRESSURE DECREASED 2 0.4000
3 URETHROSCOPY 3 0.3000
4 HEREDITARY HAEMOLYTIC ANAEMIA 2 0.2857
5 GARDNERELLA TEST POSITIVE 7 0.2258
6 PERIPROSTHETIC METALLOSIS 3 0.2000
7 NODULAR LYMPHOCYTE PREDOMINANT HODGKIN LYMPHOMA 4 0.1429
8 WARM AUTOIMMUNE HAEMOLYTIC ANAEMIA 10 0.0901
9 NONINFECTIOUS MYELITIS 6 0.0741
See all enriched reactions for RITUXIMAB-ABBS